Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy
Kisspeptin-10
Research-Only

Kisspeptin-10

Research-Grade

Kisspeptin-10 (KP-10) is the minimally active C-terminal decapeptide of kisspeptin-54, the endogenous ligand of the KISS1R (GPR54) receptor. Kisspeptin neurons in the arcuate and anteroventral periventricular nuclei of the hypothalamus are the upstream regulators of GnRH pulsatility — they are the hormonal 'master switch' that initiates puberty, maintains reproductive cyclicity, and integrates metabolic signals with reproductive function. Kisspeptin-10 has been administered IV in over a dozen human studies at Imperial College London and other centers. At low doses it robustly stimulates LH and FSH secretion within minutes, making it a precise diagnostic probe of hypothalamic-pituitary-gonadal axis integrity. At higher or repeated doses, it has been studied as a potential fertility treatment, particularly for triggering oocyte maturation in IVF with substantially lower ovarian hyperstimulation risk compared to hCG triggers. Beyond reproduction, kisspeptin signaling intersects with metabolic regulation: KISS1R is expressed in pancreatic beta cells and adipose tissue, and kisspeptin administration affects insulin secretion and psychosexual arousal in human studies.

Specifications

Origin / ManufacturerSynthetic
Active Components
Kisspeptin-10 acetateMannitol (lyoprotectant)
StorageLyophilized: −20°C. Reconstituted: 2–8°C
Shelf LifeLyophilized 12+ months; reconstituted 7–14 days refrigerated
Form FactorLyophilized powder (research vial)

Clinical Evidence

Dhillo et al. (2005, JCEM): first human study — IV kisspeptin-54 potently stimulated LH/FSH in healthy men

Clinical report reference

Jayasena et al. (2014): kisspeptin-54 SC triggered oocyte maturation in IVF with zero cases of OHSS (vs 7% with hCG)

Clinical report reference

Comninos et al. (2017): kisspeptin-54 enhanced limbic brain activity during sexual stimuli in healthy men (fMRI study)

Clinical report reference

Multiple Imperial College London studies: >500 subjects have received kisspeptin with an excellent safety profile

Clinical report reference

Frequently Asked Questions

Sources & References

Every clinical claim on this page traces to a primary peer-reviewed source.

  1. 1Dhillo WS, Chaudhri OB, Patterson M, et al.. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. Journal of Clinical Endocrinology & Metabolism. 2005;90(12):6609-6615. doi:10.1210/jc.2005-1468 PMID:16174713
  2. 2Jayasena CN, Abbara A, Comninos AN, et al.. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. Journal of Clinical Investigation. 2014;124(8):3667-3677. doi:10.1172/JCI75730 PMID:25036713
  3. 3Comninos AN, Wall MB, Demetriou L, et al.. Kisspeptin modulates sexual and emotional brain processing in humans. Journal of Clinical Investigation. 2017;127(2):709-719. doi:10.1172/JCI89519 PMID:28112679

Reviewed by

Clinical Research Review Board

Reproductive Endocrinology Review

All clinical claims cross-checked against primary sources. Read our editorial policy →

Related Peptides

Reviewed by Clinical Research Review BoardReproductive Endocrinology Review

Search

Search across products, blog posts, wiki articles, and more.